Sunshine Biopharma is a pharmaceutical company focused on the development of drugs for the treatment of aggressive forms of cancer. In addition, Sunshine offers generic pharmaceuticals, Essential Brand dietary supplements, and certified analytical chemistry services.

Generic Drugs - Coming Soon

SBI-Anastrozole for treatment of Breast Cancer
SBI-Letrozole for treatment of Breast Cancer
SBI-Bicalutamide treatment of Prostate Cancer
SBI-Finasteride for treatment of BPH (Benign Prostatic Hyperplasia)

By prescription only.
Not available in the United States.

Press Releases

May 16, 2019
Sunshine Biopharma Announces that Essential 9™ is Now Available in the United States on Amazon.com

March 12, 2019
Sunshine Biopharma Announces That ESSENTIAL 9™ Is Now Available On amazon.ca

February 4, 2019
Sunshine Biopharma Receives Notice Of Allowance For A New Patent Application Extending Protection Of Adva-27a Anticancer Drug Until 2033

December 17, 2018
Sunshine Biopharma Receives Health Canada Approval for Essential 9™, The Company's First Over The Counter Essential Micronutrient

December 12, 2018
Sunshine Biopharma Signs an Agreement With Crocus Laboratories for Manufacturing of Adva-27a Anticancer Drug

September 14, 2018
Sunshine Biopharma Announces $10 Million Equity Financing

August 16, 2018
Sunshine Biopharma Signs A Service Agreement With Utah Based Quintessential Biosciences Inc.

June 18, 2018
Sunshine Biopharma Launches Microbiology Testing Service

May 10, 2018
Sunshine Biopharma Annouces Extension Of The Term Of Its Brokered Up To $10 Million Private Placement Financing

January 4, 2018
Sunshine Biopharma Completes the Acquisition of Atlas Pharma